Nowadays the value of personalized and precision medicine is already a reality. From PRONACERA we have a high experience in evaluating and personalizing the effectiveness of different polyphenols in cellular systems and personalization platforms especially in rare diseases. From this approach, screening platforms have been designed that can be the starting point for any pharmacist who wishes to expand the profile of active compounds already tested, thus being able to increase their portfolio:
- Evaluation of effective drugs for mitochondrial diseases with yeasts, fibroblasts and mitochondrial cybrids.
- Personalised Medicine: complex clinical cases where the most effective treatment is unknown. Using patient’s fibroblasts to study the effectiveness of FDA approved drugs or commonly used in clinical.
- Evaluation of orphan indications of active ingredients of pharmaceutical companies